Know Cancer

or
forgot password

Retrospective Observational Study Of Subjects With Cytokine-Refractory Metastatic Renal Cancer Treated With Axitinib (AG-013736) To Estimate 5-Yr Survival


N/A
18 Years
N/A
Not Enrolling
Both
Carcinoma, Renal Cell

Thank you

Trial Information

Retrospective Observational Study Of Subjects With Cytokine-Refractory Metastatic Renal Cancer Treated With Axitinib (AG-013736) To Estimate 5-Yr Survival


Subjects participating in this observational study originally participated in study A4061012
[NCT00076011], and may have also have participated in study A4061008 [NCT00828919].
Subjects participating in this observational study originally participated in study A4061012
[NCT00076011], and may have also have participated in study A4061008 [NCT00828919].

5-year survival information to be updated.


Inclusion Criteria:



- Subjects participating in this observational study originally participated in study
A4061012 [NCT00076011] and may have also participated in study A4061008
[NCT00828919]

Exclusion Criteria:

- Subjects who withdrew from the original study A4061012 [NCT00076011] or the
continuing access study A4061008 [NCT00828919]

Type of Study:

Observational

Study Design:

Time Perspective: Retrospective

Outcome Measure:

Overall Survival (OS)

Outcome Description:

Overall survival is the duration from first dose of study medication to death. For participants who are alive, overall survival is censored at the last contact.

Outcome Time Frame:

Baseline until death or up to Year 5

Safety Issue:

No

Principal Investigator

Pfizer CT.gov Call Center

Investigator Role:

Study Director

Investigator Affiliation:

Pfizer

Authority:

United States: Food and Drug Administration

Study ID:

A4061065

NCT ID:

NCT01056263

Start Date:

April 2010

Completion Date:

December 2010

Related Keywords:

  • Carcinoma, Renal Cell
  • retrospective trial
  • 5-year survival
  • metastatic renal cancer cell
  • Carcinoma
  • Carcinoma, Renal Cell
  • Kidney Neoplasms

Name

Location

Pfizer Investigational SiteBlendora, California  91740
Pfizer Investigational SiteCincinnait, Ohio  45236
Pfizer Investigational SiteBronx, New York  10461
Pfizer Investigational SiteNorth Adams, Massachusetts  01247
Pfizer Investigational SiteMilwaukee, Wisconsin  53215